Corcept Therapeutics
CORT
#2417
Rank
S$7.87 B
Marketcap
$74.69
Share price
2.11%
Change (1 day)
131.72%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of December 2024 : S$0.51 Billion

According to Corcept Therapeutics 's latest financial reports the company has S$0.51 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.52 B7.14%
2023-12-31S$0.48 B-15.97%
2022-12-31S$0.57 B91.5%
2021-12-31S$0.30 B-48.17%
2020-12-31S$0.58 B56.7%
2019-12-31S$0.37 B31.71%
2018-12-31S$0.28 B137.98%
2017-12-31S$0.11 B59.13%
2016-12-31S$74.58 M30.41%
2015-12-31S$57.19 M78.52%
2014-12-31S$32.03 M-53.92%
2013-12-31S$69.52 M-38.89%
2012-12-31S$0.11 B121.64%
2011-12-31S$51.32 M62.13%
2010-12-31S$31.65 M-5.51%
2009-12-31S$33.5 M27.97%
2008-12-31S$26.18 M4.78%
2007-12-31S$24.98 M72.34%
2006-12-31S$14.49 M-70.05%
2005-12-31S$48.41 M-20.65%
2004-12-31S$61.01 M210.2%
2003-12-31S$19.66 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$32.69 B 6,297.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.47 B 2,732.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.80 B 3,382.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$4.56 B 793.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.30 B 5,241.82%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.25 B 3,471.04%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.19 B-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.26 B-48.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.51 B 196.79%๐Ÿ‡บ๐Ÿ‡ธ USA